Follow-on biologics [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007

• Pubblicazione: Washington : , : U.S. G.P.O., , 2008
• Descrizione fisica: 1 electronic text (iv, 78 pages) : HTML, digital, PDF file
• Soggetto topico: Pharmaceutical biotechnology - Government policy - United States; Pharmaceutical biotechnology - United States; Pharmaceutical technology - Government policy - United States; Drug development - Government policy - United States
• Note generali: Title from title screen (viewed on Nov. 17, 2008).; Paper version available for sale by the Supt. of Docs., U.S. G.P.O.
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Follow-on biologics
• Titolo autorizzato: Follow-on biologics
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910698695203321
• Lo trovi qui: Univ. Federico II